Determinants of Response to Sequential Pembrolizumab with Trastuzumab Plus Platinum/5FU in HER2-positive Gastric Cancer: A Phase II Chemoimmunotherapy Trial
Clin. Cancer Res., February 17 2025 | https://doi.org/10.1158/1078-0432.CCR-24-3528
Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease
Ann. Oncol., Volume 28, Issue 9, 1 September 2017, Pages 2199-2205 | https://doi.org/10.1093/annonc/mdx316
![[NEB] NEB 신제품 소식! 무료 샘플 신청도 함께 만나보세요!](/app/board/attach/image/1343716_1767836736000.do?)
